SCHEMBL16633472

SCHEMBL16633472

N#Cc1cccc(NCCCCO)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.45
IDO1 P14902 1/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.44
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
NOS1 P29475 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HDAC4 P56524 1/20 0.41
MEF2D Q14814 1/20 0.41
NPC1 O15118 1/20 0.41
NFKB1 P19838 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11114890 0.95 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL5712396 0.90 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL10019234 0.88 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL16633231 0.84 GRM4 (0.43) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL28133362 0.84 ABL1 (0.44) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL11115631 0.83 ALDH1A1 (0.59) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL3476587 0.83 ABL1 (0.47) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL11113276 0.82 GRM4 (0.44) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL14155105 0.82 TLR8 (0.47) ALDH1A1MAPTKMT2AIDO1MEN1
SCHEMBL31475206 0.80 ALDH1A1 (0.50) ALDH1A1IDO1KCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238632-B2 3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs NHWA Pharma, Corporation (CN) 2016-01-19 US disclosed
US-20150105399-A1 3-CYANOANILINOALKYLARYLPIPERAZINE DERIVATIVE AND USE THEREOF IN PREPARING DRUGS SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105399-A1 3-CYANOANILINOALKYLARYLPIPERAZINE DERIVATIVE AND USE THEREOF IN PREPARING DRUGS HTR5A, HTR3C, HTR3A ALDH1A1 670/4885MAPT 4330/4885KMT2A 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.